Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Shionogi-ViiV

- PMLiVE

Second darapladib failure disappoints GSK

Drug unable to demonstrate effectiveness in acute coronary syndrome

China flag thumb

China targets UK exec in GSK corruption probe

Former GSK China manager Mark Reilly said to have ordered sales team to bribe doctors

- PMLiVE

MPs grill Read over Pfizer’s commitments to UK

CEO faces combative parliamentary hearing over AstraZeneca bid

EU flag

Europe extends clinical trial project with African researchers

Partnership has already developed eight improved medical treatments

- PMLiVE

GSK clear to launch COPD hope Anoro in Europe

Strengthens respiratory platform ahead of patent expiry for Advair/Seretide

GW hires Pfizer’s Kenneth Sommerville

Appointed VP clinical research at company specialising in cannabinoids

- PMLiVE

AZ circles wagons as Pfizer hints at hostile takeover

Aims for annual revenues of $45bn by 2023

- PMLiVE

Pfizer faces opposition to AZ takeover as Q1 figures disappoint

Labour leader Ed Miliband calls for public inquiry into deal

- PMLiVE

UPDATE: AZ rejects improved Pfizer bid

Continues to assert independence as Pfizer appeals to Prime Minister David Cameron

- PMLiVE

Breo off to slow start in US as Advair slips, says GSK

And China issues continue to affect sales performance

- PMLiVE

GSK’s COPD drug Incruse cleared in Europe

Medicine is GSK’s first long-acting muscarinic antagonist

- PMLiVE

Pfizer confirms interest in AstraZeneca megamerger

Says it has twice tried to engage in merger talks with big pharma rival

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links